CAS No. |
110657-98-2 |
|---|---|
中文名称 |
(5S,6R,7E,9E,11Z,13E,15S,17Z)-5,6,15-三羟基二十碳-7,9,11,13,17-五烯酸 |
英文名称 |
(5S,6R,7E,9E,11Z,13E,15S,17Z)-5,6,15-Trihydroxyicosa-7,9,11,13,17-pentaenoic acid |
别名 |
5S,6R,15S-TRIHYDROXY-7E,9E,11Z,13E,17Z-EICOSAPENTAENOIC ACID;LXA5;ZZMKOZNTEJVKRY-YJUORNCYSA-N;7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S,17Z)-;Lipoxin A5,Lipoxin A-5 |
标准英文名 |
(5S,6R,7E,9E,11Z,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid |
分子式 |
C20H30O5 |
分子量 |
350.45 |
精确分子量 |
350.21 |
SMILES |
CC/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(O)=O |
标准SMILES |
CC/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(O)=O |
用途 |
Lipoxin A5 slowly contracts guinea pig lung parenchymal strips with a potency similar to that of LXA4 and LXB4.2; however, unlike LXA4 and LXB4.2, it does not exhibit vasodilatory effects on aortic smooth muscle. |
InChIKey |
ZZMKOZNTEJVKRY-YJUORNCYSA-N |
|
|
评论 |
|---|